ISPOR Europe 2023 Home
  • About
    • News Center
  • Award Winners
  • Program
    • Program
    • Student Program
    • Learning Formats
    • Plenary Sessions
    • Posters
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsor List
    • Exhibitor Directory
    • Media Partners
  • Photo Gallery
large-circle

ISPOR Europe 2023

12 - 15 November

  • Home
  • Events
  • Past Conferences
  • ISPOR Europe 2023
  • Program
  • Plenary Sessions
  • Session

  • Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Adults and Adolescents Aged 12 Years and Older With Resected Stage IIB/IIC Melanoma in France

    Nov 15, 2023, 09:00 AM
  • «
  • 461
  • 462 (current)
  • 463
  • 464
  • 465
  • 466
  • 467
  • 468
  • 469
  • 470
  • »
Quick Links
  • Membership
  • Upcoming Conferences & Events
  • Exhibits & Sponsorships
  • Good Practices Reports & More
  • Value in Health
  • Contact Us
Policies & Legal
  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions

Site Map

Media/Press

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group